GDPR-Safe Pharma Direct Mail with Interactive Paper
Reach HCPs and patients with NFC-enabled direct mail that is GDPR-compliant by design. Production is EU-based, data hosting is EU-only, and analytics are consent-first and aggregated — so you measure real engagement without PII leakage. Compliance and measurability stop being a trade-off.
Why is compliance built into the foundation?
Interactive Paper is produced in the EU and is fully GDPR-compliant, with an optional HIPAA configuration for stricter healthcare workflows. Data is hosted EU-only, so the regulatory exposure that worries pharma marketing and compliance teams is addressed at the infrastructure level, not bolted on afterwards.
How do you track without exposing personal data?
Our analytics are consent-first and can stay fully aggregated: you see tap volume, timing, device and city-level geography without identifying individuals. When a campaign is personalised, recipient data is handled under GDPR and connected to your CRM under your own governance — never leaked into third-party tooling.
Built for HCP engagement and patient communication
From HCP engagement mailers to patient leaflets and clinical-trial communication, a single tap opens clear digital guidance with no app required. In clinical-trial leaflets we measured a 38% improvement in correct first-dose self-administration. See more on our healthcare solutions page.
Measurable, compliant, and CRM-connected
Every interaction flows into a real-time dashboard you can connect to your systems via API. The result is pharma direct mail with digital-grade accountability. Explore the broader product in interactive direct mail.
Frequently asked questions
Is Interactive Paper direct mail GDPR / DSGVO compliant?
Yes. Our production is EU-based and fully GDPR-compliant, with EU-only data hosting and an optional HIPAA configuration. Analytics are designed to be consent-first and aggregated, so you measure engagement without exposing personal data.
How do you protect HCP and patient data?
Tap data is captured at the level you need — for non-personalised mailings this is aggregated engagement only, with no PII. When mailings are personalised, recipient identity is handled under GDPR with EU-only hosting and can be connected to your CRM under your own controls.
Can this support clinical-trial and patient-leaflet communication?
Yes. NFC-enabled leaflets let patients tap for clear, on-demand guidance. In clinical-trial leaflets we measured a 38% improvement in correct first-dose self-administration, while keeping the data layer compliant by design.
Do recipients need an app to engage?
No. A single tap opens the digital experience directly in the browser — no app, no QR scan and no login. This lowers friction for HCPs and patients while keeping the consent and data model under control.
Découvrez comment Interactive Paper peut vous aider à attirer de nouveaux clients !
Découvrez comment Interactive Paper peut vous aider à attirer de nouveaux clients !
Consultez nos experts : ils vous montreront comment moderniser vos projets marketing grâce à Interactive Paper.
